GLOBAL BLOOD THERAPEUTICS IN

Q2 2022 13F Holders

CUSIP
37890U108
Type
Equity
Class
COM
Num filings
205
Total reported value, excl. options
$2.29 B
Manager Report Date Value ($000) Shares Option Type